Universität Wien
Course Exam

301908 VO Development of novel cancer immunotherapies (2023S)

from target identification through target validation to clinical trials

3.00 ECTS (2.00 SWS), SPL 30 - Biologie
ON-SITE

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).

Examiners

Information

Assessment and permitted materials

Written exam, alternative: presentation

Minimum requirements and assessment criteria

Understanding of the basic mechanisms of resistance development and of newest technologies

Last modified: Tu 19.03.2024 16:06